» Articles » PMID: 19378745

Design of Optimal Collimation for Dedicated Molecular Breast Imaging Systems

Overview
Journal Med Phys
Specialty Biophysics
Date 2009 Apr 22
PMID 19378745
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Molecular breast imaging (MBI) is a functional imaging technique that uses specialized small field-of-view gamma cameras to detect the preferential uptake of a radiotracer in breast lesions. MBI has potential to be a useful adjunct method to screening mammography for the detection of occult breast cancer. However, a current limitation of MBI is the high radiation dose (a factor of 7-10 times that of screening mammography) associated with current technology. The purpose of this study was to optimize the gamma camera collimation with the aim of improving sensitivity while retaining adequate resolution for the detection of sub-10-mm lesions. Square-hole collimators with holes matched to the pixilated cadmium zinc telluride detector elements of the MBI system were designed. Data from MBI patient studies and parameters of existing dual-head MBI systems were used to guide the range of desired collimator resolutions, source-to-collimator distances, pixel sizes, and collimator materials that were examined. General equations describing collimator performance for a conventional gamma camera were used in the design process along with several important adjustments to account for the specialized imaging geometry of the MBI system. Both theoretical calculations and a Monte Carlo model were used to measure the geometric efficiency (or sensitivity) and resolution of each designed collimator. Results showed that through optimal collimation, collimator sensitivity could be improved by factors of 1.5-3.2, while maintaining a collimator resolution of either < or =5 or < or = 7.5 mm at a distance of 3 cm from the collimator face. These gains in collimator sensitivity permit an inversely proportional drop in the required dose to perform

Citing Articles

Bias and precision of SPECT-based Lu activity-concentration estimation using a ring-configured solid-state versus a dual-headed anger system.

Stenvall A, Ceric Andelius I, Nilsson E, Lindvall A, Larsson E, Gustafsson J EJNMMI Phys. 2024; 11(1):91.

PMID: 39489825 PMC: 11532328. DOI: 10.1186/s40658-024-00693-5.


The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery.

Collarino A, Olmos R, van Berkel L, Neijenhuis P, Wijers L, Smit F Breast Cancer Res Treat. 2018; 169(3):513-522.

PMID: 29435855 PMC: 5953986. DOI: 10.1007/s10549-018-4706-1.


Molecular Breast Imaging using Synthetic Projections from High-Purity Germanium Detectors: A Simulation Study.

Campbell D, Peterson T IEEE Trans Radiat Plasma Med Sci. 2017; 1(5):405-415.

PMID: 28989990 PMC: 5629019. DOI: 10.1109/TRPMS.2017.2725310.


Comparison of Tc-99m maraciclatide and Tc-99m sestamibi molecular breast imaging in patients with suspected breast cancer.

OConnor M, Morrow M, Hunt K, Boughey J, Wahner-Roedler D, Conners A EJNMMI Res. 2017; 7(1):5.

PMID: 28091980 PMC: 5237435. DOI: 10.1186/s13550-017-0255-6.


An energy-optimized collimator design for a CZT-based SPECT camera.

Weng F, Bagchi S, Zan Y, Huang Q, Seo Y Nucl Instrum Methods Phys Res A. 2015; 806:330-339.

PMID: 26640308 PMC: 4665111. DOI: 10.1016/j.nima.2015.09.115.


References
1.
Mueller B, OConnor M, Blevis I, Rhodes D, Smith R, Collins D . Evaluation of a small cadmium zinc telluride detector for scintimammography. J Nucl Med. 2003; 44(4):602-9. View

2.
Hruska C, OConnor M, Collins D . Comparison of small field of view gamma camera systems for scintimammography. Nucl Med Commun. 2005; 26(5):441-5. DOI: 10.1097/00006231-200505000-00008. View

3.
Coover L, Caravaglia G, Kuhn P . Scintimammography with dedicated breast camera detects and localizes occult carcinoma. J Nucl Med. 2004; 45(4):553-8. View

4.
Hruska C, OConnor M . Quantification of lesion size, depth, and uptake using a dual-head molecular breast imaging system. Med Phys. 2008; 35(4):1365-76. PMC: 2673627. DOI: 10.1118/1.2885371. View

5.
Humphrey L, Helfand M, Chan B, Woolf S . Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002; 137(5 Part 1):347-60. DOI: 10.7326/0003-4819-137-5_part_1-200209030-00012. View